JPRN-UMIN000039635招募中未知
Study of glucagon response and its association with glycemic control and variability after administration of ipragliflozin as an adjunctive to insulin treatment in patients with type 1 diabetes (Suglat-AID): a single-arm, multicenter, open-label, prospective exploratory trial - Suglat-AID
agasaki University Hospital0 个研究点目标入组 24 人开始时间: 2020年3月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with any of the following will be excluded: (1) Use of any SGLT2 inhibitors within 12 months before enrollment. (2) A previous history of ketoacidosis within 12 months before enrollment. (3) An eating disorder. (4) Regular consumption of a low-carbohydrate diet. (5) Alcohol abuse or alcohol consumption >20 g/day. (6) Severe renal dysfunction defined as an estimated glomerular filtration rate <30 mL/min/1.73m2. (7) Severe anemia defined as a hemoglobin level <10 g/dL. (8) Hypersensitivity or allergy to SGLT2 inhibitors including ipragliflozin. (9) Body mass index (BMI) <20.0 kg/m2. (10) Previous history of repeated severe hypoglycemia, urinary tract infection or genital infection. (11) Pregnancy or breastfeeding. (12) HbA1c levels >11% at enrollment. (13) Judged inappropriate to participate by the study investigators.
研究者
相似试验
进行中（未招募）
不适用
Testing Whether Glucagon Solutions Affect the Glucose Levels in the Fat Tissue of Diabetic Patients.EUCTR2014-002341-22-ATMedizinische Universität Graz; Universitätsklinik für InnereMedizin; Abteilung für Endokrinologie und Stoffwechsel
已完成
不适用
Effect of the glucagon suppression ability in the sulfonylurea agents and other oral hypoglycemic agents.Type 2 diabetesJPRN-UMIN000007378Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine200
已完成
不适用
Evaluation of change in blood glucagon levels in response to orally glucose loading and food intakeDiabetes mellitusJPRN-UMIN000027852Gunma University70
已完成
不适用
Alternation in glucagon secretion associated with progression of glucose intolerance.normal glucose tolerance, impaired glucose metabolism, Type 2 diabetes mellitus (non-insulin dependent)JPRN-UMIN000016133Kitasato University School of Medicine53
进行中（未招募）
1 期
effects of glucagon on the heart and circulatioEUCTR2019-002638-36-DKBispebjerg Hospital, University of Copenhagen8